Knight

From OpenWetWare
Jump to navigationJump to search

<html><style type='text/css'> .tabs {

 width: 750px;
 font-family: trebuchet ms;

}

.tabs strong{

 color: #602;

} </style></html>

CSAIL logo
Knight Lab



About Us

  1. Lab Members
  2. Contact
  3. Video (Knight & Endy labs)
  4. Projects
  5. Publications

Technical Info

  1. Equipment
  2. Materials
  3. Protocols

Internal

  1. Freezer Inventory
  2. Fridge Inventory
  3. Dyes Inventory
  4. Orders
  5. Punchlist
  6. Safety

Related sites

  1. Biography
  2. Website
  3. Old page
  4. Dictionary.com entry
  5. Wikipedia page

<wikionly>

Recent changes

List of abbreviations:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes

21 May 2024

20 May 2024

     19:36  CHEM-ENG590E:Wiki Textbook diffhist −125 Sarah L. Perry talk contribs (→‎Chapter 9 - Microfluidics and Cell Culture)
     19:33  Organ/Tumor/Body-on-a-Chip - Organ on a Chip - Michele Caggioni‎‎ 47 changes history −3,630 [Sarah L. Perry‎ (47×)]
     
19:33 (cur | prev) −2,021 Sarah L. Perry talk contribs
     
19:32 (cur | prev) +69 Sarah L. Perry talk contribs (→‎Future Work and Ultimate Goals)
     
19:31 (cur | prev) −3 Sarah L. Perry talk contribs (→‎Body-on-a-chip Limitations)
     
19:30 (cur | prev) +9 Sarah L. Perry talk contribs (→‎Body-on-a-chip Advantages)
     
19:28 (cur | prev) +2 Sarah L. Perry talk contribs
     
19:25 (cur | prev) +523 Sarah L. Perry talk contribs (→‎Scalability of Tumor-On-A-Chip Based Drug Screening)
     
19:25 (cur | prev) +1,250 Sarah L. Perry talk contribs (→‎Drug Screening)
     
19:20 (cur | prev) −1,679 Sarah L. Perry talk contribs (→‎Body-on-a-chip Limitations)
     
19:19 (cur | prev) −355 Sarah L. Perry talk contribs
     
19:12 (cur | prev) −31 Sarah L. Perry talk contribs (→‎Organ-on-a-Chip Advantages and Disadvantages)
     
19:11 (cur | prev) +8 Sarah L. Perry talk contribs (→‎Body-on-a-chip Advantages)
     
19:10 (cur | prev) −100 Sarah L. Perry talk contribs (→‎Body-on-a-chip (integration of multiple organ-on-a-chips) Advantages & Limitations)
     
19:08 (cur | prev) +4 Sarah L. Perry talk contribs (→‎Scalability of Tumor-On-A-Chip Based Drug Screening)
     
19:07 (cur | prev) −480 Sarah L. Perry talk contribs (→‎Scalability of Tumor-On-A-Chip Based Drug Screening)
     
19:02 (cur | prev) −40 Sarah L. Perry talk contribs (→‎Drug Screening)
     
18:58 (cur | prev) −14 Sarah L. Perry talk contribs (→‎Modeling)
     
18:56 (cur | prev) −134 Sarah L. Perry talk contribs (→‎Tumor Spheroid Production)
     
18:52 (cur | prev) +3 Sarah L. Perry talk contribs (→‎Tumor Spheroid Production)
 m   
18:51 (cur | prev) −1 Sarah L. Perry talk contribs (→‎Role of Microfluidics in Cancer Research)
     
18:51 (cur | prev) +9 Sarah L. Perry talk contribs (→‎Role of Microfluidics in Cancer Research)
 m   
18:50 (cur | prev) +21 Sarah L. Perry talk contribs (→‎Role of Microfluidics in Cancer Research Abroad)
     
18:46 (cur | prev) +9 Sarah L. Perry talk contribs (→‎Modeling Drug Delivery: Overview and Motivation)
     
18:45 (cur | prev) +4 Sarah L. Perry talk contribs (→‎Modeling Non-Cancerous Cell Components of the Tumor Microenvironment)
     
18:45 (cur | prev) +14 Sarah L. Perry talk contribs (→‎Modeling Non-Cancerous Cell Components of the Tumor Microenvironment)
     
18:45 (cur | prev) −4 Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)
     
18:44 (cur | prev) +12 Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)
     
18:44 (cur | prev) +8 Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)
     
18:43 (cur | prev) +14 Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)
     
18:43 (cur | prev) +10 Sarah L. Perry talk contribs (→‎Modeling Non-Cancerous Cell Components of the Tumor Microenvironment)
     
18:42 (cur | prev) +9 Sarah L. Perry talk contribs (→‎Modeling the Biochemical Regulation of Cancer Proliferation)
     
18:40 (cur | prev) −92 Sarah L. Perry talk contribs (→‎Introduction-Modeling Tumor Death: Microfluidics and Biomimetic Tumor Spheroids)
     
18:35 (cur | prev) −166 Sarah L. Perry talk contribs (→‎Introduction-Modeling Tumor Death: Microfluidics and Biomimetic Tumor Spheroids)
 m   
18:32 (cur | prev) −1 Sarah L. Perry talk contribs (→‎Kidney-on-a-Chip)
 m   
18:29 (cur | prev) 0 Sarah L. Perry talk contribs (→‎Lung-on-a-Chip)
 m   
18:28 (cur | prev) +1 Sarah L. Perry talk contribs (→‎Liver-on-a-Chip)
     
18:24 (cur | prev) −61 Sarah L. Perry talk contribs (→‎Kidney-on-a-Chip)
     
18:23 (cur | prev) −60 Sarah L. Perry talk contribs (→‎Lung-on-a-Chip)
     
18:22 (cur | prev) −62 Sarah L. Perry talk contribs (→‎Liver-on-a-Chip)
     
18:21 (cur | prev) −1 Sarah L. Perry talk contribs
     
18:20 (cur | prev) −14 Sarah L. Perry talk contribs (→‎Liver-on-a-Chip)
     
18:18 (cur | prev) +16 Sarah L. Perry talk contribs (→‎Body-on-a-chip)
     
18:17 (cur | prev) −246 Sarah L. Perry talk contribs (→‎Body-on-a-chip)
     
18:07 (cur | prev) +3 Sarah L. Perry talk contribs (→‎Body-on-a-chip)
 m   
17:52 (cur | prev) +4 Sarah L. Perry talk contribs (→‎Body-on-a-chip)
     
17:51 (cur | prev) −44 Sarah L. Perry talk contribs (→‎Organ-on-a-chip Advantages)
 m   
17:48 (cur | prev) 0 Sarah L. Perry talk contribs (→‎Organ on a Chip Advantages and Disadvantages)
     
17:47 (cur | prev) −23 Sarah L. Perry talk contribs (→‎Conventional Systems)

</wikionly>